The store will not work correctly when cookies are disabled.
N-((5'-methoxy-1'-methyl-2'-oxospiro[cyclopropane-1,3'-indoline]-2-yl)methyl)acetamide
ID: ALA4076136
PubChem CID: 137649044
Max Phase: Preclinical
Molecular Formula: C15H18N2O3
Molecular Weight: 274.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2c(c1)C1(CC1CNC(C)=O)C(=O)N2C
Standard InChI: InChI=1S/C15H18N2O3/c1-9(18)16-8-10-7-15(10)12-6-11(20-3)4-5-13(12)17(2)14(15)19/h4-6,10H,7-8H2,1-3H3,(H,16,18)
Standard InChI Key: LUNWUHNKUBTAEO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
18.9935 -10.4378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2093 -9.3647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4764 -9.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2135 -10.1901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4953 -8.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5036 -10.5987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7978 -9.3647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7896 -10.1901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0336 -8.1513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2935 -9.7532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0952 -8.9559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3867 -9.3632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2520 -11.2130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2823 -7.3729 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0808 -7.1991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3296 -6.4207 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6306 -7.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9894 -9.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2370 -8.3246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4377 -8.5002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 1 1 0
18 3 1 0
4 1 1 0
5 2 2 0
6 4 2 0
7 8 2 0
8 6 1 0
9 19 1 0
18 2 1 0
5 7 1 0
3 10 2 0
11 12 1 0
7 11 1 0
1 13 1 0
9 14 1 0
14 15 1 0
15 16 2 0
15 17 1 0
19 18 1 0
20 19 1 0
18 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 274.32 | Molecular Weight (Monoisotopic): 274.1317 | AlogP: 1.07 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.64 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 0.05 | CX LogD: 0.05 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.90 | Np Likeness Score: 0.13 |
References
1. Zaryanova EV, Lozinskaya NA, Beznos OV, Volkova MS, Chesnokova NB, Zefirov NS.. (2017) Oxindole-based intraocular pressure reducing agents., 27 (16): [PMID:28687205] [10.1016/j.bmcl.2017.06.065] |